General
Advarra Publishes the State of Clinical Trial Activation at Sites Report
Advarra has published a report providing actionable solutions to streamline study activation and maximize operational efficiency
Cheryl Byers and Dr. John H. Stewart Discuss Diversity, Equity and Inclusion in Cancer Research
Diversity, equity, and inclusion (DEI) in cancer research are critical to clinical research. In this episode, Advarra’s Cheryl Byers and Dr. John H. Stewart have a discussion on what is DEI, the current climate of DEI in cancer research, and considerations to improve DEI in clinical trial enrollment and retention.
The State of Clinical Trial Activation at Sites Report
View our report on actions to streamline study activaiton and maximize operational efficiency.
Advarra Announces Release of Insights Accrual Prediction Platform, A Next-Generation Accrual Prediction Solution For Clinical Trials
Insights Accrual Prediction platform leverages machine learning to accurately predict protocol accrual, strengthening clinical research success.
Advarra Acquires Bio-Optronics, Maker of Clinical Conductor TrialSuite™
Advarra today announced that it has acquired Bio-Optronics, maker of CCTrialSuite
Biosafety, Ethical, and Logistical Challenges to Pursuing a Coronavirus Vaccine at Warp Speed
The SARS-CoV-2 pandemic has impacted all aspects of society. Various government and private groups around the world are endeavoring to develop safe and effective vaccines at an unprecedented pace and scale to quell the pandemic as quickly as possible.
Advarra Announces New Gene Therapy Ready Site Network
Learn more about Advarra's new Gene Therapy Ready Site Network.
Expanding Our Global Consulting Expertise to Solve Mission-Critical Issues
Elevating our consulting capabilities to accelerate clinical research and bring therapies to market sooner.
Advarra Acquires YourEncore, a Leading Provider of Drug Development and Commercialization Advisory and Consulting Services
YourEncore significantly expands Advarra’s consulting capabilities to address mission-critical challenges for the biopharmaceutical industry
By the Numbers: Our Response to COVID-19
We are honored to support a resilient research community during the COVID-19 pandemic. Explore our resources to find out how we keep research moving forward.
Coming Together to Benefit the Greater Research Community
Advarra acquires Longboat to help advance clinical research and accelerate drug development.
Tips for Writing Effective Edit Checks in eCRFs
Learn how to write effective edit checks in electronic case report forms (eCRFs) to help improve data quality in electronic data capture systems.